NTLA-2002

Intellia’s CRISPR drug could offer one-shot HAE treatment
Pharmaphorum
Thu, 02/1/24 - 11:26 am
Intellia Therapeutics
HAE
clinical trials
CRISPR
gene editing
NTLA-2002
CRISPR on the Cusp: The Promise and the Pain Points
BioSpace
Mon, 07/10/23 - 09:27 pm
Intellia Therapeutics
HAE
NTLA-2002
CRISPR
Patients attack-free a year after receiving Intellia's hereditary angioedema CRISPR med
Fierce Biotech
Sun, 06/11/23 - 11:07 pm
Intellia Therapeutics
HAE
hereditary angiodema
CRISPR
NTLA-2002
Intellia doses first patient as hereditary angioedema gene editing therapy lands in clinic
Fierce Biotech
Mon, 12/13/21 - 11:46 pm
Intellia Therapeutics
HAE
clinical trials
NTLA-2002